🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Manning & Napier Group’s BIIB Holdings & Trades

First Buy
Q1 2017
Duration Held
39 Quarters
Largest Add
Q2 2017
+691,694 Shares
Current Position
26 Shares
$6,558 Value

Manning & Napier Group's BIIB Position Overview

Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 26 shares of Biogen Inc. (BIIB) worth $6,558, representing 0.00% of the portfolio. First purchased in 2017-Q1, this long-term strategic position has been held for 39 quarters.

Based on 13F filings, Manning & Napier Group has maintained a strategic position in BIIB, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2017, adding 691,694 shares. Largest reduction occurred in Q4 2017, reducing 331,082 shares.

Analysis based on 13F filings available since 2013 Q2

Manning & Napier Group's Biogen (BIIB) Holding Value Over Time

Track share changes against reported price movement

Quarterly Biogen (BIIB) Trades by Manning & Napier Group

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +26 New Buy 26 $252.23
Q4 2018 -178,560 Sold Out 178,560 $353.30
Q3 2018 -38,930 Reduce 17.90% 178,560 $353.30
Q2 2018 -172,760 Reduce 44.27% 217,490 $290.23
Q1 2018 -16,403 Reduce 4.03% 390,250 $273.81
Q4 2017 +406,654 Add 0.00% 406,653 $318.57
Q3 2017 -76,634 Reduce 9.41% 737,735 $313.12
Q2 2017 +691,694 Add 563.84% 814,369 $271.36
Q1 2017 +122,675 New Buy 122,675 $273.41

Manning & Napier Group's Biogen Investment FAQs

Manning & Napier Group first purchased Biogen Inc. (BIIB) in Q1 2017, acquiring 122,675 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Manning & Napier Group has held Biogen Inc. (BIIB) for 39 quarters since Q1 2017.

Manning & Napier Group's largest addition to Biogen Inc. (BIIB) was in Q2 2017, adding 814,369 shares worth $220.99 M.

According to the latest 13F filing for Q3 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 26 shares of Biogen Inc. (BIIB), valued at approximately $6,558.

As of the Q3 2026 filing, Biogen Inc. (BIIB) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.

Manning & Napier Group's peak holding in Biogen Inc. (BIIB) was 814,369 shares, as reported at the end of Q2 2017.